SEARCH

SEARCH BY CITATION

References

  • 1
    Chung, J.H., Seo, J.Y., Choi, H.R., et al. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J. Invest. Dermatol. 117(5), 12181224 (2001).
  • 2
    Watson, R.E., Long, S.P., Bowden, J.J., Bastrilles, J.Y., Barton, S.P. and Griffiths, C.E. Repair of photoaged dermal matrix by topical application of a cosmetic ‘antiageing’ product. Br. J. Dermatol. 158(3), 472477 (2007).
  • 3
    Tzaphlidou, M. The role of collagen and elastin in aged skin: an image processing approach. Micron 35(3), 173177 (2004).
  • 4
    Fisher, G.J., Kang, S., Varani, J., et al. Mechanisms of photoaging and chronological skin aging. Arch. Dermatol. 138(11), 14621470 (2002).
  • 5
    McCullough, J.L. and Kelly, K.M. Prevention and treatment of skin aging. Ann. N. Y. Acad. Sci. 1067(1), 323331 (2006).
  • 6
    Ramos-e-Silva, M. and da Silva Carneiro, S.C. Elderly skin and its rejuvenation: Products and procedures for the aging skin. J. Cosmet. Dermatol. 6(1), 4050 (2007).
  • 7
    Graf, J. Anti-aging skin care ingredient technologies. In: Cosmetic Dermatology. (Burgess, C.M., ed.), pp. 1728. Springer-Verlag Berlin and Heidelberg GmbH & Co. KG, Berlin (2005).
  • 8
    El-Domyati, M., Attia, S., Saleh, F., et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp. Dermatol. 11(5), 398405 (2002).
  • 9
    Goldsmith, L.A. Physiology, Biochemistry, and Molecular Biology of the Skin, Vol. II, 2nd edn. Oxford University Press, New York (1991).
  • 10
    Choi, C.M. and Berson, D.S. Cosmeceuticals. Semin. Cutan. Med. Surg. 25(3), 163168 (2006).
  • 11
    Barrett, G.C. and Elmore, D.T. Amino acids and peptides. Cambridge University Press, Cambridge (1998).
  • 12
    Lupo, M.P. and Cole, A.L. Cosmeceutical peptides. Dermatol. Ther. 20(5), 343349 (2007).
  • 13
    Lintner, K. Promoting production in the extracellular matrix without compromising barrier. Cutis. 70 (6 Suppl.), 1316; discussion 21–23 (2002).
  • 14
    Draelos, Z.D. The latest cosmeceutical approaches for anti-aging. J. Cosmet. Dermatol. 6(s1), 26 (2007).
  • 15
    Gorouhi, F. and Maibach, H.I. Role of topical peptides in preventing or treating aged skin. Int. J. Cosmet. Sci. 31(5), 327345 (2009).
  • 16
    Katayama, K., Armendariz-Borunda, J., Raghow, R., Kang, A.H. and Seyer, J.M. A pentapeptide from type I procollagen promotes extracellular matrix production. J. Biol. Chem. 268(14), 99419944 (1993).
  • 17
    Katayama, K., Seyer, J.M., Raghow, R. and Kang, A.H. Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide. Biochemistry 30(29), 70977104 (1991).
  • 18
    Tsai, W.C., Hsu, C.C., Chung, C.Y., Lin, M.S., Li, S.L. and Pang, J.H. The pentapeptide KTTKS promoting the expressions of type I collagen and transforming growth factor-beta of tendon cells. J. Orthop. Res. 25(12), 16291634 (2007).
  • 19
    Namjoshi, S., Caccetta, R. and Benson, H.A. Skin peptides: biological activity and therapeutic opportunities. J. Pharm. Sci. 97(7), 25242542 (2008).
  • 20
    Opsahl, W.P. and Ehrhart, L.A. Compartmentalization of proline pools and apparent rates of collagen and non-collagen protein synthesis in arterial smooth muscle cells in culture. Biochem. J. 243(1), 137144 (1987).
  • 21
    Pouillot, A., Dayan, N., Polla, A.S., Polla, L.L. and Polla, B.S. The stratum corneum: A double paradox. J. Cosmet. Dermatol. 7(2), 143148 (2008).
  • 22
    Lau, W.M., White, A.W., Gallagher, S.J., Donaldson, M., McNaughton, G. and Heard, C.M. Scope and limitations of the co-drug approach to topical drug delivery. Curr. Pharm. Des. 14(8), 794802 (2008).
  • 23
    Williams, A. Transdermal and Topical Drug Delivery: From Theory to Clinical Practice. Pharmaceutical Press, London (2003).
  • 24
    Benson, H., Caccetta, R., Chen, Y., Kearns, P. and Toth, I. Transdermal delivery of a tetrapeptide: Evaluation of passive diffusion. Int. J. Peptide Res. Therap. 10(5), 615620 (2003).
  • 25
    Hadgraft, J. Skin, the final frontier. Int. J. Pharmaceut. 224(1–2), 118 (2001).
  • 26
    Potts, R.O. and Guy, R.H. Predicting skin permeability. Pharmaceut. Res. 9(5), 663669 (1992).
  • 27
    ACDLabs. ACD/ChemSketch, 12.01 edn. Advanced Chemistry Development, Inc, Toronto (2009).
  • 28
    NIOSH. Skin Permeation Calculator. Centers for Disease Control and Prevention, Atlanta (2010).
  • 29
    Morganti, P., Ruocco, E., Wolf, R. and Ruocco, V. Percutaneous absorption and delivery systems. Clin. Dermatol. 19(4), 489501 (2001).
  • 30
    Kanikkannan, N., Kandimalla, K., Lamba, S.S. and Singh, M. Structure–activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 7, 593608 (2000).
  • 31
    Aungst, B.J., Blake, J.A. and Hussain, M.A. Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharmaceut. Res. 7(7), 712718 (1990).
  • 32
    Heard, C.M., Kung, D. and Thomas, C.P. Skin penetration enhancement of mefenamic acid by ethanol and 1,8-cineole can be explained by the “pull” effect. Int. J. Pharmaceut. 321(1–2), 167170 (2006).
  • 33
    Foldvari, M., Attah-Poku, S., Hu, J., et al. Palmitoyl derivatives of interferon alpha: potential for cutaneous delivery. J. Pharm. Sci. 87(10), 12031208 (1998).
  • 34
    Lintner, K. and Peschard, O. Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. Int. J. Cosmet. Sci. 22(3), 207218 (2000).
  • 35
    Robinson, L.R., Fitzgerald, N.C., Doughty, D.G., Dawes, N.C., Berge, C.A. and Bissett, D.L. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int. J. Cosmet. Sci. 27(3), 155160 (2005).
  • 36
    Stillman, M.A., Maibach, H.I. and Shalita, A.R. Relative irritancy of free fatty acids of different chain length. Contact Dermatitis 1(2), 6569 (1975).
  • 37
    Sloan, K.B. Prodrugs: Topical and Ocular Drug Delivery. Marcel Dekker, New York, (1992).
  • 38
    Lin, R.-Y., Hsu, C.-W. and Chen, W.-Y. A method to predict the transdermal permeability of amino acids and dipeptides through porcine skin. J. Control. Rel. 38(2–3), 229234 (1996).
  • 39
    Testa, B. and Mayer, J. Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry and Enzymology. Helvitica Chimica Acta Verlag, Weinheim (2003).
  • 40
    Yoshioka, S. and Stella, V.J. Stability of Drugs and Dosage Forms. Plenum Publishing Co., New York (2000).
  • 41
    Satoh, T. and Hosokawa, M. THE MAMMALIAN CARBOXYLESTERASES: from molecules to functions. Annu. Rev. Pharmacol. Toxicol. 38(1), 257288 (1998).
  • 42
    Choi, H.-I., Kim, H.-J., Park, J.-I., Shin, E.-H., Kim, D.-W. and Kim, S.-S. Design and efficient synthesis of novel ascorbyl conjugated peptide with high collagen biosynthesis stimulating effects. Bioorg. Med. Chem. Lett. 19(7), 20792082 (2009).
  • 43
    Park, J.-I., Kim, H.-J., Kim, D.-W., et al. Stabilized vitamin C derivatives having a peptide molecule, preparation method thereof, and composition containing the same. South Korea patent WO/2007/148847. World Intellectual Property Organization, (2007).
  • 44
    Hadgraft, J. and Guy, R.H. Transdermal Drug Delivery: Developmental Issues and Research Initiatives. Dekker, New York (1989).
  • 45
    Bronaugh, R.L. and Maibach, H.I. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methodology, 4th edn. Taylor & Francis, Boca Raton, FL, London (2005).
  • 46
    Steinsträsser, I. and Merkle, H.P. Dermal metabolism of topically applied drugs: pathways and models reconsidered. Pharmaceut. Acta Helvetiae 70(1), 324 (1995).
  • 47
    Martin, R.J., Denyer, S.P. and Hadgraft, J. Skin metabolism of topically applied compounds. Int. J. Pharmaceut. 39(1–2), 2332 (1987).
  • 48
    Boderke, P., Merkle, H.P., Cullander, C., Ponec, M. and Bodde, H.E. Localization of aminopeptidase activity in freshly excised human skin: direct visualization by confocal laser scanning microscopy. J. Investig. Dermatol. 108(1), 8386 (1997).
  • 49
    Zhou, X.H. and Li Wan Po, A. Comparison of enzymic activities of tissues lining portals of drug absorption, using the rat as a model. Int. J. Pharmaceut. 62(2–3), 259267 (1990).
  • 50
    Storm, E.J., Collier, W.S., Stewart, F.R. and Bronaugh, L.R. Metabolism of xenobiotics during percutaneous penetration: Role of absorption rate and cutaneous enzyme activity. Toxicol. Sci. 15(1), 132141 (1990).
  • 51
    Williams, F.M. Potential for metabolism locally in the skin of dermally absorbed compounds. Human Exp. Toxicol. 27(4), 277280 (2008).
  • 52
    Lupo, M.P. Cosmeceutical peptides. Dermatol. Surg. 31(s1), 832836 (2005).
  • 53
    Osborne, R., Robinson, L., Mullins, L., Raleigh, P., Li, J. and Miyamoto, K. Use of a Facial Moisturizer Containing Pal-KTTKS Peptide. 63rd American Academy of Dermatology Annual Meeting , New Orleans, (2005).
  • 54
    Levin, J. and Maibach, H.I. The correlation between transepidermal water loss and percutaneous absorption: an overview. In: Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methodology (Bronaugh, R.L. and Maibach, H.I., eds), 4th edn, pp. 583593. Taylor & Francis, Boca Raton, FL; London (2005).
  • 55
    Guttman, C. Studies demonstrate value of procollagen fragment Pal-KTTKS. Dermatol. Times. 23, 68 (2002).
  • 56
    Rona, C., Vailati, F. and Berardesca, E. The cosmetic treatment of wrinkles. J. Cosmet. Dermatol. 3(1), 2634 (2004).
  • 57
    Fernandes, D. Evolution of cosmeceuticals and their application to skin disorders, including aging and blemishes. In: Dermatologic, Cosmeceutic, and Cosmetic Development: Therapeutic and Novel Approaches (Walters, K.A. and Roberts, M.S., eds), pp. 4560, Ilustrated edn. Informa Healthcare USA. Inc., New York (2008).
  • 58
    Fu, J.J.J., Hillebrand, G.G., Raleigh, P., et al. A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0·02% tretinoin product regimen. Br. J. Dermatol. 162(3), 647654 (2010).
  • 59
    Prausnitz, M.R., Mitragotri, S. and Langer, R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3(2), 115124 (2004).
  • 60
    Naik, A., Kalia, Y.N. and Guy, R.H. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm. Sci. Technol. Today 3(9), 318326 (2000).
  • 61
    Alvarez-Román, R., Naik, A., Kalia, Y.N., Fessi, H. and Guy, R.H. Visualization of skin penetration using confocal laser scanning microscopy. Eur. J. Pharmaceut. Biopharmaceut. 58(2), 301316 (2004).
  • 62
    Singka, G.S.L., Samah, N.A., Zulfakar, M.H., Yurdasiper, A. and Heard, C.M. Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel. Eur. J. Pharmaceut. Biopharmaceut. 76(2), 275281 (2010).
  • 63
    Samah, N.A., Williams, N. and Heard, C.M. Nanogel particulates located within diffusion cell receptor phases following topical application demonstrates uptake into and migration across skin. Int. J. Pharmaceut. 401(1–2), 7278 (2010).